{
    "eid": "2-s2.0-85092720817",
    "title": "Outcomes of pre-early treatment for retinopathy of prematurity (Pre-etrop)",
    "cover-date": "2020-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Ophthalmology",
            "@code": "2731",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Outcomes",
        "Pre-early treatment for retinopathy of prematurity",
        "Regression",
        "Retinopathy of prematurity"
    ],
    "authors": [
        "Yothin Titawattanakul",
        "Kittisak Kulvichit",
        "Adisai Varadisai",
        "Apivat Mavichak"
    ],
    "citedby-count": 2,
    "ref-count": 15,
    "ref-list": [
        "Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: implications for screening programs",
        "Retinopathy of prematurity in middle-income countries",
        "Time at treatment of severe retino-pathy of prematurity in China: recommendations for guidelines in more mature infants",
        "Retinopathy of prematurity blindness worldwide: pheno-types in the third epidemic",
        "Preterm birth\u2013associated neu-rodevelopmental impairment estimates at regional and global levels for 2010",
        "Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010",
        "Blindness, low vision and eye diseases in Thai children 2006\u20132007",
        "Retinopathy of prematurity",
        "Multicenter trial of cryotherapy for retinopathy of prematurity. Preliminary results",
        "15-year outcomes following threshold retinopathy of prematurity: final outcomes from the multi-center trial of cryotherapy for retinopathy of prematurity",
        "Early treatment for Retinopathy of prematurity cooperative group. Final results of the early treatment for retinopathy of prematurity (ETROP) randomized trial",
        "Screening examination of premature infants for retinopathy of prematurity",
        "Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity",
        "Progression of type 2 to type 1 retinopathy of prematurity in the early treatment for retino-pathy of prematurity study"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60028190",
        "affilname": "Chulalongkorn University",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
        "affiliation-country": "Thailand"
    },
    "funding": [
        "Chulalongkorn University"
    ]
}